Overview: Heparin is a blood thinner that is used to prevent or treat blood clots. It may be injected under the skin or into a blood vessel. The most common side effects are irritation at the ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

A before-and-after comparison following the exclusion of heparin from continuous infusions through PICCs placed by a designated team. Duration of use was assessed during epochs immediately preceding ...

Heparin is an anionic polysaccharide that has tremendous clinical importance as an anticoagulant. Several dyes have been developed that can detect heparin, and the latest example — named Mallard Blue ...

Blood thinners don’t really thin your blood. They just interrupt your body’s natural clotting process. Warfarin and heparin act on different parts of this process. Doctors usually prescribe warfarin ...

UFH is a mixture of glycosaminoglycans of varying lengths (mean 15,000 daltons; range 3000-30,000 daltons). This heterogeneity results in variable anticoagulant activity and pharmacokinetics. In fact, ...

Anecdotal reports of subtherapeutic heparin have kept many cardiologists across the world on edge over the past couple of months, although no regulatory authority has yet confirmed a specific problem.

I am nurse and I been working at Hospital over a year now. I work dialysis unit. Most patient get heparin to prevent from clotting their blood while they are on the dialysis machine. heparin derived ...

Heparin is an anticoagulant drug or blood thinner which is used to treat or prevent the formation of blood clots in conditions like deep vein thrombosis, arterial thromboembolism, pulmonary embolism, ...

Researchers moved one step closer to the ability to make heparin in cultured cells. Heparin is a potent anti-coagulant and the most prescribed drug in hospitals, yet cell-culture-based production of ...

New research reveals that patients receiving heparin therapy were diagnosed with Alzheimer's disease up to two years later, suggesting a possible protective effect of this common anticoagulant. Study: ...